Evidence map›Paper›PMID 41783984›Full record

ArticleJournal of cell science2026

ERK inhibits Capicua repressor function via multisite phosphorylation.

Sayantanee Paul, Khandan Ilkhani, Nathan Strozewski, Liu Yang, David W Denberg, Wootchelmine Christalin, Vanessa Locke, Stanislav Y Shvartsman, Alexey Veraksa

Abstract read
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sayantanee PaulDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Khandan IlkhaniDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Nathan StrozewskiDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Liu YangLewis Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA.
David W DenbergLewis Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA.
Wootchelmine ChristalinDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Vanessa LockeDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.
Stanislav Y ShvartsmanLewis Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA.
Alexey VeraksaDepartment of Biology, University of Massachusetts Boston, Boston, MA 02125, USA.ORCID 0000-0003-2920-080X

Funding

Collective dynamics in cell clustersR01GM134204 · NIGMS · PRINCETON UNIVERSITY · PI Stanislav Y. Shvartsman · 2019 to 2026
$2.6M
Mechanisms of signal integration in developmental control of organ size and tissue patterningR01GM141843 · NIGMS · UNIVERSITY OF MASSACHUSETTS BOSTON · PI VERAKSA, ALEXEY · 2021 to 2024
$1.2M
Signaling networks controlling organ growth and tissue patterningR35GM158116 · NIGMS · UNIVERSITY OF MASSACHUSETTS BOSTON · PI Alexey Veraksa · 2025 to 2026
$848k
NIGMS NIH HHS GM141843NIGMS NIH HHS GM158116NIGMS NIH HHS R01 GM134204NIGMS NIH HHS R01 GM141843NIGMS NIH HHS R35 GM158116NIH HHS GM141843NIH HHS GM158116OraclePrinceton UniversitySanofiUniversity of Massachusetts Boston
6 · The paper itself

Abstract

The receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase (ERK) signaling pathway controls cell proliferation, differentiation and survival. The transcriptional repressor Capicua (Cic) has emerged as a key target for ERK-mediated downregulation in Drosophila and mammals, and pathogenic variants in human CIC result in cancer and neurological diseases. Phosphorylation by ERK (Rolled in flies) is critical for Cic downregulation, but the identities of phosphosites in Drosophila Cic are unknown. Here, we identify sites of phosphorylation in Cic that are directly targeted by ERK and validate their developmental functions in vivo using mutant Cic variants. Cic phosphosites are distributed throughout the length of the protein. Cic mutated in 20 high-confidence sites is resistant to proteasomal degradation and behaves as a 'super-repressor' in vivo that is largely insensitive to ERK-mediated downregulation. No single site is sufficient to turn off Cic activity; instead, we find that ERK must phosphorylate multiple sites in Cic simultaneously to achieve full downregulation. This multisite phosphorylation likely involves phosphodegrons that are recognized by ubiquitin ligases such as Ago (FBXW7 in mammals), contributing to Cic degradation. This study advances our understanding of the molecular mechanisms of signal interpretation downstream of the RTK/ERK signaling network.

Indexed as

Drosophila melanogasterDrosophila ProteinsExtracellular Signal-Regulated MAP KinasesRepressor ProteinsAnimalsHMGB ProteinsHumansPhosphorylationcic protein, DrosophilaDrosophila ProteinsExtracellular Signal-Regulated MAP KinasesHMGB ProteinsRepressor ProteinsCapicuaDrosophilaERKMultisite phosphorylationPhosphodegron

Identifiers

PMID41783984
PMCPMC13086492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.